BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 8176210)

  • 1. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S; Deckhut AM; Blackman MA; Woodland DL
    J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the TCR alpha-chain to the differential recognition of bacterial and retroviral superantigens.
    Daly K; Nguyen P; Hankley D; Zhang WJ; Woodland DL; Blackman MA
    J Immunol; 1995 Jul; 155(1):27-34. PubMed ID: 7602104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
    Borrero H; Donson D; Cervera C; Rexer C; Macphail S
    J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterotoxin residues determining T-cell receptor V beta binding specificity.
    Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
    Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
    Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
    J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
    Pullen AM; Bogatzki LY
    J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.
    Choi YW; Herman A; DiGiusto D; Wade T; Marrack P; Kappler J
    Nature; 1990 Aug; 346(6283):471-3. PubMed ID: 2377208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
    Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
    Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor alpha-chain influences reactivity to Mls-1 in V beta 8.1 transgenic mice.
    Smith HP; Le P; Woodland DL; Blackman MA
    J Immunol; 1992 Aug; 149(3):887-96. PubMed ID: 1321853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
    Yagi J; Baron J; Buxser S; Janeway CA
    J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.